initial Combination therapy in PAH -ERA , PDE -VI and prostacyclin (IV , s/c and oral ) : Recommendation Evidence. #PAH #combinationtherapy

Big news and an extremely proud announcement today.

Joint Operations are delighted to be appointed UK distribution partners with #Breg . One of the world’s largest bracing companies.

We can’t wait to tell you more, further updates to follow. #savethejoint #CombinationTherapy

New #ESI report has been published with record 53 TOP papers, including 7 Hot Papers. I'm so happy that our #SI #metaanalysis is already highly cited, as we are working on the first SI #score , and our #ILEP 2021 #recommendations on the #combinationtherapy , which we soon update‼️

Another reason to consider #combinationtherapy from the beginning in the highest/extremely high #risk #patients , when in even 30% we might also observe elevated #LPA . Here you have a clear recommendations in those groups being on baseline #statin #therapy . academic.oup.com/eurheartj/arti…

no words can adequately describe getting to watch “my study” [Dr. Jain’s study that I manage] presented at #ASH19 by the best PI I know, Nitin Jain | #teamCLL #gotvenetoclax #CLL #combinationtherapy

New Hope for #LungCancer Patients : #CombinationTherapy Breaks Through Resistance Barrier

Our latest newsletter explores the growing market potential of combination therapy in lung cancer treatment.

Detailed report at lnkd.in/gjA5BDNW

#LungCancer #CombinationTherapy

This phase 1b study showed that triplet therapy with ven, ibr, + ritux was feasible but had low activity in the cohort of mainly primary refractory, heavily pre-treated pts with #DLBCL . Read more 👉bit.ly/3ywY9dw
#lymsm #lymphoma #CombinationTherapy #RelapsedRefractory

The combination of vismodegib and #radiotherapy is an effective treatment for locally advanced unresectable basal cell carcinoma, highlighting the potential of #CombinationTherapy #SkinCancer #CancerTreatment #BasalCellCarcinoma #Vismodegib #TREASURE

ascopubs.org/doi/10.1200/JC…

Excellent presentation by Julio Rosenstock at the Dual #Incretin symposium at #ADA2022 . We need to change the paradigm. Start with #combinationtherapy !

#TACE + #Durvalumab + #Bevacizumab demonstrates superior PFS (23% reduced risk) when compared to #TACE alone for the treatment of #hepatocellularcarcinoma .

Congratulations to the #Emerald1 investigators. Welcome the #combinationtherapy era.🧩

astrazeneca.com/media-centre/p…

So nice to see that our paper on the #upfront #lipid lowering #combinationtherapy based on the data from the Polish #ACS #Registry is within ‼️the Top Ten Early Interest Research Contributions to JAHA in 2023‼️ Thanks!

Congratulations again to all co-authors!

Glad to share our work on remodeling #ColdTumor by #CombinationTherapy  (ISIM: in situ immunomodulation) comprised of #Flt3L   #radiotherapy and #CD40 / #TLR3 agonists to maximize the engagement of intratumoral  #cDC1 #DendriticCells  published in Nature Communications rdcu.be/b9gBN

#NOX XON presented at 2018 #ESMOIO ! Aram Mangasarian and the Team are here to answer your questions on our latest clinical data. #NOX -A12 / #Keytruda #immunooncology #combinationtherapy #immunotherapy #colorectalcancer #pancreaticcancer see Poster: bit.ly/2zZZ47P

Very proud of our poster highlighting #combinationtherapy for #gastriccancer #Immunotherapy #ASCO23

PDS Biotechnology and National Cancer Institute have identified the optimal treatment group in the ongoing development of the PDS0101-based triple combination therapy in advanced HPV-positive cancers. Read more: pdsbiotech.com/investors/news…
#clinicalresearch #biotechnology #cancerresearch #combinationtherapy

Our paper is now published in Materials Horizons Materials Horizons. ' #Bacteria #StarvationTherapy + Infection #Immunotherapy = Infection #CombinationTherapy ' Biofabrikation David Kilian Humboldt-Stiftung #Humboldtian . pubs.rsc.org/en/content/art…

Emerald-1 is positive. How will the data readout impact your MDT?🧩
astrazeneca.com/media-centre/p… #HCC #AstraZeneca #Durvalumab #TACE #combinationtherapy

#WCIRDC2021 Program Highlight: Dr. Erin D. Michos, M.D. will discuss #NovelAgents and #CombinationTherapy in Management of #Dyslipidemia . To see more of this session, register at wcir.org/registration

Johns Hopkins Medicine Johns Hopkins University #meded #cardioed #medicalconference #ascvd #cvd #cme

#FoodandDrugAdministration #FDA #Approves #Novartis #CombinationTherapy For #AggressiveThyroidCancer # Tafinlar #Mekinist

It's been a busy poster session at #ESMO19 today. Preliminary Results from our Phase 2 Trial Evaluating DPX-Survivac as a #CombinationTherapy in #patients with advanced and metastatic #SolidTumors were presented at the #Immunotherapy session.
Find out more:bit.ly/2oFDWkl